Fig. 5
From: Targeting neddylation E2s: a novel therapeutic strategy in cancer
UBE2M-DCN1 inhibitors. a The crystal structure of the interaction between DCN1 and the UBE2M peptide is shown in yellow (PDB 3TDU). b–g Chemical structures of UBE2M-DCN1 inhibitors